Search results for

NPR's Ari Shapiro talks Juan Carlos Pinzon, Colombia's ambassador to the U.S., about his country's agreement to receive 4,000 Afghans while their paperwork to go to America is being processed.

School boards and superintendents are facing backlash over mask and vaccination policies. What were once nonpartisan public service jobs have now become more political — and dangerous.

The Afghan restaurant Lapis in Washington D.C., owned by a family of Afghan immigrants who fled in the 1980s, has been accepting donations to help Afghan refugees who are expected in the area.

President Obama campaigns this week in Ohio, Florida and Virginia — three key states where a new poll shows him leading Republican rival Mitt Romney. An important question this election season is: Which candidate will do a better of job of getting his supporters to the polls in November?

In The Knockoff Economy, Kal Raustiala and Christopher Sprigman say that in the world of fashion, copycats make styles go in and out of vogue faster. Copying breeds competition, Raustiala says, and that makes clothes cheaper for consumers.

Rep. Ron Paul, who challenged Mitt Romney during the GOP primary season, hasn't endorsed Romney. Paul won't be speaking at the convention, which upsets his supporters. At Sunday's rally, thousands cheered the loudest when Paul repeated his anti-war message, and called for an end to the Federal Reserve.

It's the first trading day since Apple's win in a huge U.S. patent battle with competitor Samsung. The South Korean company was ordered to pay more than a billion dollars in damages after a California jury found it copied features of Apple's iPhone and iPad.

At StoryCorps, Charlene Jarvis spoke with her son Ernest about the legacy of her father, Charles Drew, a doctor who developed a way to get life-saving blood plasma to soldiers during World War II.

Secretary of State Antony Blinken offers an update on a massive evacuation effort from Afghanistan. Lawmakers and European allies fear many will be left behind if Biden keeps an "arbitrary deadline."

Immediately after the Food and Drug Administration authorized Pfizer's vaccine, the company delivered fewer doses than its government contract projected. Federal officials say they didn't know why.